Viewing Opinion | StockChase
Valeant Pharmaceuticals (VRX-T) opinion on 2017-03-20

Last Price Recorded: 20.9600 on 2017-11-23

ON STOCKCHASE SINCE Oct 2000

Consumer Products
COMMENT

Lyle Stein
Valeant Pharmaceuticals was $14.200 at time of opinion
Owned : No

Struggling with massive amounts of debt, which was acquired when everything was looking great. The problem was, the assets they bought they probably overpaid for by using cheap paper. $30 billion is a lot of debt and he doesn’t know how they overcome it. He doesn’t like bottom fishing.

CAUTIOUS

All opinions for VRX-T (701)

127 BUY
19 BUY on WEAKNESS
68 COMMENT
253 DON'T BUY
30 HOLD
1 PARTIAL BUY
2 PARTIAL SELL
40 PAST TOP PICK
21 SELL
5 STRONG BUY
68 TOP PICK
25 WAIT
15 WATCH
27 WEAK BUY
View All

More experts covering VRX-T

SAVE
Add VRX-T to Watch List

All opinions for VRX-T (701)

127 BUY
19 BUY on WEAKNESS
68 COMMENT
253 DON'T BUY
30 HOLD
1 PARTIAL BUY
2 PARTIAL SELL
40 PAST TOP PICK
21 SELL
5 STRONG BUY
68 TOP PICK
25 WAIT
15 WATCH
27 WEAK BUY
View All

More experts covering VRX-T

SAVE
Add VRX-T to Watch List

No Comments.


You must be logged in to comment.

Successfully Saved Company